Gang Liu1, Fuhua Wu1, Xiaoli Jiang1, Yumei Que1, Zhexue Qin2, Pingping Hu1, Kin Sing Stephen Lee3,4, Jian Yang5, Chunyu Zeng6, Bruce D Hammock3, Xiaoyong Tong1. 1. School of Pharmaceutical Sciences, Chongqing University, Chongqing, China. 2. Department of Cardiovascular Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing, China. 3. Department of Entomology & UCD Comprehensive Cancer Center, University of California-Davis, Davis, California. 4. Department of Pharmacology & Toxicology, Michigan State University, East Lansing, Michigan. 5. Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China. 6. Department of Cardiology, Daping Hospital, Third Military Medical University, Chongqing, China.
Abstract
BACKGROUND AND PURPOSE: The kidney is essential in regulating sodium homeostasis and BP. The irreversible oxidation of Cys674 (C674) in the sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) is increased in the renal cortex of hypertensive mice. Whether inactivation of C674 promotes hypertension is unclear. Here we have investigated the effects on BP of the inactivation of C674, and its role in the kidney. EXPERIMENTAL APPROACH: We used heterozygous SERCA2 C674S knock-in (SKI) mice, where half of C674 was substituted by serine, to represent partial irreversible oxidation of C674. The BP, urine volume, and urine composition of SKI mice and their littermate wild-type (WT) mice were measured. The kidneys were collected for cell culture, Na+ /K+ -ATPase activity, protein expression, and immunohistological analysis. KEY RESULTS: Compared with WT mice, SKI mice had higher BP, lower urine volume and sodium excretion, up-regulated endoplasmic reticulum (ER) stress markers and soluble epoxide hydrolase (sEH), and down-regulated dopamine D1 receptors in renal cortex and cells from renal proximal tubule. ER stress and sEH were mutually regulated, and both upstream of D1 receptors. Inhibition of ER stress or sEH up-regulated expression of D1 receptors, decreased the activity of Na+ /K+ -ATPase, increased sodium excretion, and lowered BP in SKI mice. CONCLUSIONS AND IMPLICATIONS: The inactivation of SERCA2 C674 promotes the development of hypertension by inducing ER stress and sEH. Our study highlights the importance of C674 redox status in BP control and the contribution of SERCA2 to sodium homeostasis and BP in the kidney.
BACKGROUND AND PURPOSE: The kidney is essential in regulating sodium homeostasis and BP. The irreversible oxidation of Cys674 (C674) in the sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) is increased in the renal cortex of hypertensive mice. Whether inactivation of C674 promotes hypertension is unclear. Here we have investigated the effects on BP of the inactivation of C674, and its role in the kidney. EXPERIMENTAL APPROACH: We used heterozygous SERCA2 C674S knock-in (SKI) mice, where half of C674 was substituted by serine, to represent partial irreversible oxidation of C674. The BP, urine volume, and urine composition of SKI mice and their littermate wild-type (WT) mice were measured. The kidneys were collected for cell culture, Na+ /K+ -ATPase activity, protein expression, and immunohistological analysis. KEY RESULTS: Compared with WT mice, SKI mice had higher BP, lower urine volume and sodium excretion, up-regulated endoplasmic reticulum (ER) stress markers and soluble epoxide hydrolase (sEH), and down-regulated dopamine D1 receptors in renal cortex and cells from renal proximal tubule. ER stress and sEH were mutually regulated, and both upstream of D1 receptors. Inhibition of ER stress or sEH up-regulated expression of D1 receptors, decreased the activity of Na+ /K+ -ATPase, increased sodium excretion, and lowered BP in SKI mice. CONCLUSIONS AND IMPLICATIONS: The inactivation of SERCA2 C674 promotes the development of hypertension by inducing ER stress and sEH. Our study highlights the importance of C674 redox status in BP control and the contribution of SERCA2 to sodium homeostasis and BP in the kidney.
Authors: Todd R Harris; Ahmed Bettaieb; Sean Kodani; Hua Dong; Richard Myers; Nipavan Chiamvimonvat; Fawaz G Haj; Bruce D Hammock Journal: Toxicol Appl Pharmacol Date: 2015-03-28 Impact factor: 4.219
Authors: Steve P H Alexander; Richard E Roberts; Brad R S Broughton; Christopher G Sobey; Christopher H George; S Clare Stanford; Giuseppe Cirino; James R Docherty; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Jonathan Mangum; Sue Wonnacott; Amrita Ahluwalia Journal: Br J Pharmacol Date: 2018-02 Impact factor: 8.739
Authors: Xiaoyan Wang; Yingjin Luo; Crisanto S Escano; Zhiwei Yang; Laureano Asico; Hewang Li; John E Jones; Ines Armando; Quansheng Lu; David R Sibley; Gilbert M Eisner; Pedro A Jose Journal: Hypertension Date: 2010-04-19 Impact factor: 10.190
Authors: Fuzhong Qin; Deborah A Siwik; Steve Lancel; Jingmei Zhang; Gabriela M Kuster; Ivan Luptak; Lei Wang; Xiaoyong Tong; Y James Kang; Richard A Cohen; Wilson S Colucci Journal: J Am Heart Assoc Date: 2013-08-20 Impact factor: 5.501
Authors: Jie Yang; Junli Hao; Yapeng Lin; Yijia Guo; Ke Liao; Min Yang; Hang Cheng; Ming Yang; Kejie Chen Journal: Front Genet Date: 2022-03-14 Impact factor: 4.599
Authors: Kathy K Griendling; Livia L Camargo; Francisco J Rios; Rhéure Alves-Lopes; Augusto C Montezano; Rhian M Touyz Journal: Circ Res Date: 2021-04-01 Impact factor: 17.367